Glioma Diagnosis and Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Primary Tumor, Secondary Tumour); Diagnosis (Neurological Exam, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Biopsy, Position Emission Tomography (PET) Scan, Others); Treatment (Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy); End User (Hospitals and Clinics, Diagnostic Centers, Others)

Report Code: TIPRE00019610 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

A glioma is a type of tumor that originates in the brain. There are numerous types of gliomas differentiated on the basis of origin of the cell type such as oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Technological advancements in the diagnosis of gliomas and analysis of its progression are driving the growth of the market.

MARKET DYNAMICS

The glioma diagnosis and treatment market is driving due to increasing prevalence of brain cancer, and innovations in drug delivery to brain cancer. However, lack of adoption in low-income countries is expected to hamper the growth of the global glioma diagnosis and treatment market. Moreover, the introduction of novel therapies coupled with increasing geriatric population are is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Glioma Diagnosis and Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of glioma diagnosis and treatment market with detailed market segmentation by type, diagnosis, treatment, and end-user. The glioma diagnosis and treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in glioma diagnosis and treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The glioma diagnosis and treatment market is segmented based on type, diagnosis, treatment, and end-user. Based on type, the market is segmented into primary tumor, secondary tumor. Primary tumor is segmented into ependymomas, astrocytomas, oligodendrogliomas, brainstem glioma, others. Based on diagnosis, the market is segmented into neurological exam, computed tomography (CT) scan, magnetic resonance imaging (MRI), biopsy, position emission tomography (PET) scan, others. Based on treatment, the market is segmented into surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy. Based on end user, the market is segmented into hospitals & clinics, diagnostic centers, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the glioma diagnosis and treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The glioma diagnosis and treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting glioma diagnosis and treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the glioma diagnosis and treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the glioma diagnosis and treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Glioma Diagnosis and Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for glioma diagnosis and treatment market in the global market. Below mentioned is the list of few companies engaged in the glioma diagnosis and treatment market.

The report also includes the profiles of key players in Glioma Diagnosis and Treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Thermo Fisher Scientific
  •   Pfizer Inc.
  •   Novartis AG
  •   Sun Pharmaceuticals Ltd
  •   GE Healthcare
  •   Shimadzu Corporation
  •   Siemens Healthcare
  •   TOSHIBA Medical Systems
  •   AbbVie Inc.
  •   Eisai Inc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Glioma Diagnosis And Treatment Market - By Type
1.3.2 Glioma Diagnosis And Treatment Market - By Diagnosis
1.3.3 Glioma Diagnosis And Treatment Market - By Treatment
1.3.4 Glioma Diagnosis And Treatment Market - By End User
1.3.5 Glioma Diagnosis And Treatment Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GLIOMA DIAGNOSIS AND TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GLIOMA DIAGNOSIS AND TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GLIOMA DIAGNOSIS AND TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. GLIOMA DIAGNOSIS AND TREATMENT - GLOBAL MARKET OVERVIEW
6.2. GLIOMA DIAGNOSIS AND TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GLIOMA DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PRIMARY TUMOR
7.3.1. Overview
7.3.2. Primary Tumor Market Forecast and Analysis
7.3.3. Ependymomas Market
7.3.3.1. Overview
7.3.3.2. Ependymomas Market Forecast and Analysis
7.3.4. Astrocytomas Market
7.3.4.1. Overview
7.3.4.2. Astrocytomas Market Forecast and Analysis
7.3.5. Oligodendrogliomas Market
7.3.5.1. Overview
7.3.5.2. Oligodendrogliomas Market Forecast and Analysis
7.3.6. Brainstem Glioma Market
7.3.6.1. Overview
7.3.6.2. Brainstem Glioma Market Forecast and Analysis
7.3.7. Others Market
7.3.7.1. Overview
7.3.7.2. Others Market Forecast and Analysis
7.4. SECONDARY TUMOR
7.4.1. Overview
7.4.2. Secondary Tumor Market Forecast and Analysis
8. GLIOMA DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DIAGNOSIS
8.1. OVERVIEW
8.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
8.3. NEUROLOGICAL EXAM
8.3.1. Overview
8.3.2. Neurological Exam Market Forecast and Analysis
8.4. COMPUTED TOMOGRAPHY (CT) SCAN
8.4.1. Overview
8.4.2. Computed Tomography (CT) Scan Market Forecast and Analysis
8.5. MAGNETIC RESONANCE IMAGING (MRI)
8.5.1. Overview
8.5.2. Magnetic Resonance Imaging (MRI) Market Forecast and Analysis
8.6. BIOPSY
8.6.1. Overview
8.6.2. Biopsy Market Forecast and Analysis
8.7. POSITION EMISSION TOMOGRAPHY (PET) SCAN
8.7.1. Overview
8.7.2. Position Emission Tomography (PET) Scan Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. GLIOMA DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. SURGERY
9.3.1. Overview
9.3.2. Surgery Market Forecast and Analysis
9.4. CHEMOTHERAPY
9.4.1. Overview
9.4.2. Chemotherapy Market Forecast and Analysis
9.5. RADIATION THERAPY
9.5.1. Overview
9.5.2. Radiation Therapy Market Forecast and Analysis
9.6. IMMUNOTHERAPY
9.6.1. Overview
9.6.2. Immunotherapy Market Forecast and Analysis
9.7. TARGETED THERAPY
9.7.1. Overview
9.7.2. Targeted Therapy Market Forecast and Analysis
10. GLIOMA DIAGNOSIS AND TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. DIAGNOSTIC CENTERS
10.4.1. Overview
10.4.2. Diagnostic Centers Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. GLIOMA DIAGNOSIS AND TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Glioma Diagnosis And Treatment Market Overview
11.1.2 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.1.3 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.1.4 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.1.5 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.1.6 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.1.7 North America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.1.7.1 United States Glioma Diagnosis And Treatment Market
11.1.7.1.1 United States Glioma Diagnosis And Treatment Market by Type
11.1.7.1.2 United States Glioma Diagnosis And Treatment Market by Diagnosis
11.1.7.1.3 United States Glioma Diagnosis And Treatment Market by Treatment
11.1.7.1.4 United States Glioma Diagnosis And Treatment Market by End User
11.1.7.2 Canada Glioma Diagnosis And Treatment Market
11.1.7.2.1 Canada Glioma Diagnosis And Treatment Market by Type
11.1.7.2.2 Canada Glioma Diagnosis And Treatment Market by Diagnosis
11.1.7.2.3 Canada Glioma Diagnosis And Treatment Market by Treatment
11.1.7.2.4 Canada Glioma Diagnosis And Treatment Market by End User
11.1.7.3 Mexico Glioma Diagnosis And Treatment Market
11.1.7.3.1 Mexico Glioma Diagnosis And Treatment Market by Type
11.1.7.3.2 Mexico Glioma Diagnosis And Treatment Market by Diagnosis
11.1.7.3.3 Mexico Glioma Diagnosis And Treatment Market by Treatment
11.1.7.3.4 Mexico Glioma Diagnosis And Treatment Market by End User
11.2. EUROPE
11.2.1 Europe Glioma Diagnosis And Treatment Market Overview
11.2.2 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.2.3 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.2.4 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.2.5 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.2.6 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.2.7 Europe Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Glioma Diagnosis And Treatment Market
11.2.7.1.1 Germany Glioma Diagnosis And Treatment Market by Type
11.2.7.1.2 Germany Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.1.3 Germany Glioma Diagnosis And Treatment Market by Treatment
11.2.7.1.4 Germany Glioma Diagnosis And Treatment Market by End User
11.2.7.2 France Glioma Diagnosis And Treatment Market
11.2.7.2.1 France Glioma Diagnosis And Treatment Market by Type
11.2.7.2.2 France Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.2.3 France Glioma Diagnosis And Treatment Market by Treatment
11.2.7.2.4 France Glioma Diagnosis And Treatment Market by End User
11.2.7.3 Italy Glioma Diagnosis And Treatment Market
11.2.7.3.1 Italy Glioma Diagnosis And Treatment Market by Type
11.2.7.3.2 Italy Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.3.3 Italy Glioma Diagnosis And Treatment Market by Treatment
11.2.7.3.4 Italy Glioma Diagnosis And Treatment Market by End User
11.2.7.4 Spain Glioma Diagnosis And Treatment Market
11.2.7.4.1 Spain Glioma Diagnosis And Treatment Market by Type
11.2.7.4.2 Spain Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.4.3 Spain Glioma Diagnosis And Treatment Market by Treatment
11.2.7.4.4 Spain Glioma Diagnosis And Treatment Market by End User
11.2.7.5 United Kingdom Glioma Diagnosis And Treatment Market
11.2.7.5.1 United Kingdom Glioma Diagnosis And Treatment Market by Type
11.2.7.5.2 United Kingdom Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.5.3 United Kingdom Glioma Diagnosis And Treatment Market by Treatment
11.2.7.5.4 United Kingdom Glioma Diagnosis And Treatment Market by End User
11.2.7.6 Rest of Europe Glioma Diagnosis And Treatment Market
11.2.7.6.1 Rest of Europe Glioma Diagnosis And Treatment Market by Type
11.2.7.6.2 Rest of Europe Glioma Diagnosis And Treatment Market by Diagnosis
11.2.7.6.3 Rest of Europe Glioma Diagnosis And Treatment Market by Treatment
11.2.7.6.4 Rest of Europe Glioma Diagnosis And Treatment Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Glioma Diagnosis And Treatment Market Overview
11.3.2 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.3.3 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.3.5 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.3.6 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Glioma Diagnosis And Treatment Market
11.3.7.1.1 Australia Glioma Diagnosis And Treatment Market by Type
11.3.7.1.2 Australia Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.1.3 Australia Glioma Diagnosis And Treatment Market by Treatment
11.3.7.1.4 Australia Glioma Diagnosis And Treatment Market by End User
11.3.7.2 China Glioma Diagnosis And Treatment Market
11.3.7.2.1 China Glioma Diagnosis And Treatment Market by Type
11.3.7.2.2 China Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.2.3 China Glioma Diagnosis And Treatment Market by Treatment
11.3.7.2.4 China Glioma Diagnosis And Treatment Market by End User
11.3.7.3 India Glioma Diagnosis And Treatment Market
11.3.7.3.1 India Glioma Diagnosis And Treatment Market by Type
11.3.7.3.2 India Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.3.3 India Glioma Diagnosis And Treatment Market by Treatment
11.3.7.3.4 India Glioma Diagnosis And Treatment Market by End User
11.3.7.4 Japan Glioma Diagnosis And Treatment Market
11.3.7.4.1 Japan Glioma Diagnosis And Treatment Market by Type
11.3.7.4.2 Japan Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.4.3 Japan Glioma Diagnosis And Treatment Market by Treatment
11.3.7.4.4 Japan Glioma Diagnosis And Treatment Market by End User
11.3.7.5 South Korea Glioma Diagnosis And Treatment Market
11.3.7.5.1 South Korea Glioma Diagnosis And Treatment Market by Type
11.3.7.5.2 South Korea Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.5.3 South Korea Glioma Diagnosis And Treatment Market by Treatment
11.3.7.5.4 South Korea Glioma Diagnosis And Treatment Market by End User
11.3.7.6 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market
11.3.7.6.1 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market by Type
11.3.7.6.2 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market by Diagnosis
11.3.7.6.3 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market by Treatment
11.3.7.6.4 Rest of Asia-Pacific Glioma Diagnosis And Treatment Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Glioma Diagnosis And Treatment Market Overview
11.4.2 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.4.3 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.4.5 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.4.6 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Glioma Diagnosis And Treatment Market
11.4.7.1.1 South Africa Glioma Diagnosis And Treatment Market by Type
11.4.7.1.2 South Africa Glioma Diagnosis And Treatment Market by Diagnosis
11.4.7.1.3 South Africa Glioma Diagnosis And Treatment Market by Treatment
11.4.7.1.4 South Africa Glioma Diagnosis And Treatment Market by End User
11.4.7.2 Saudi Arabia Glioma Diagnosis And Treatment Market
11.4.7.2.1 Saudi Arabia Glioma Diagnosis And Treatment Market by Type
11.4.7.2.2 Saudi Arabia Glioma Diagnosis And Treatment Market by Diagnosis
11.4.7.2.3 Saudi Arabia Glioma Diagnosis And Treatment Market by Treatment
11.4.7.2.4 Saudi Arabia Glioma Diagnosis And Treatment Market by End User
11.4.7.3 U.A.E Glioma Diagnosis And Treatment Market
11.4.7.3.1 U.A.E Glioma Diagnosis And Treatment Market by Type
11.4.7.3.2 U.A.E Glioma Diagnosis And Treatment Market by Diagnosis
11.4.7.3.3 U.A.E Glioma Diagnosis And Treatment Market by Treatment
11.4.7.3.4 U.A.E Glioma Diagnosis And Treatment Market by End User
11.4.7.4 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market
11.4.7.4.1 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market by Type
11.4.7.4.2 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market by Diagnosis
11.4.7.4.3 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market by Treatment
11.4.7.4.4 Rest of Middle East and Africa Glioma Diagnosis And Treatment Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Glioma Diagnosis And Treatment Market Overview
11.5.2 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis
11.5.3 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Type
11.5.4 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Diagnosis
11.5.5 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Treatment
11.5.6 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By End User
11.5.7 South and Central America Glioma Diagnosis And Treatment Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Glioma Diagnosis And Treatment Market
11.5.7.1.1 Brazil Glioma Diagnosis And Treatment Market by Type
11.5.7.1.2 Brazil Glioma Diagnosis And Treatment Market by Diagnosis
11.5.7.1.3 Brazil Glioma Diagnosis And Treatment Market by Treatment
11.5.7.1.4 Brazil Glioma Diagnosis And Treatment Market by End User
11.5.7.2 Argentina Glioma Diagnosis And Treatment Market
11.5.7.2.1 Argentina Glioma Diagnosis And Treatment Market by Type
11.5.7.2.2 Argentina Glioma Diagnosis And Treatment Market by Diagnosis
11.5.7.2.3 Argentina Glioma Diagnosis And Treatment Market by Treatment
11.5.7.2.4 Argentina Glioma Diagnosis And Treatment Market by End User
11.5.7.3 Rest of South and Central America Glioma Diagnosis And Treatment Market
11.5.7.3.1 Rest of South and Central America Glioma Diagnosis And Treatment Market by Type
11.5.7.3.2 Rest of South and Central America Glioma Diagnosis And Treatment Market by Diagnosis
11.5.7.3.3 Rest of South and Central America Glioma Diagnosis And Treatment Market by Treatment
11.5.7.3.4 Rest of South and Central America Glioma Diagnosis And Treatment Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GLIOMA DIAGNOSIS AND TREATMENT MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. GLIOMA DIAGNOSIS AND TREATMENT MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. PFIZER INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. NOVARTIS AG
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. SUN PHARMACEUTICALS LTD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. GE HEALTHCARE
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. SHIMADZU CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. SIEMENS HEALTHCARE
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. TOSHIBA MEDICAL SYSTEMS
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ABBVIE INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. EISAI INC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Thermo Fisher Scientific
2. Pfizer Inc.
3. Novartis AG
4. Sun Pharmaceuticals Ltd
5. GE Healthcare
6. Shimadzu Corporation
7. Siemens Healthcare
8. TOSHIBA Medical Systems
9. AbbVie Inc.
10. Eisai Inc
TIPRE00019610
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking